<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37759469</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>18</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Obatoclax Rescues FUS-ALS Phenotypes in iPSC-Derived Neurons by Inducing Autophagy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2247</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12182247</ELocationID><Abstract><AbstractText>Aging is associated with the disruption of protein homeostasis and causally contributes to multiple diseases, including amyotrophic lateral sclerosis (ALS). One strategy for restoring protein homeostasis and protecting neurons against age-dependent diseases such as ALS is to de-repress autophagy. BECN1 is a master regulator of autophagy; however, is repressed by BCL2 via a BH3 domain-mediated interaction. We used an induced pluripotent stem cell model of ALS caused by mutant FUS to identify a small molecule BH3 mimetic that disrupts the BECN1-BCL2 interaction. We identified obatoclax as a brain-penetrant drug candidate that rescued neurons at nanomolar concentrations by reducing cytoplasmic FUS levels, restoring protein homeostasis, and reducing degeneration. Proteomics data suggest that obatoclax protects neurons via multiple mechanisms. Thus, obatoclax is a candidate for repurposing as a possible ALS therapeutic and, potentially, for other age-associated disorders linked to defects in protein homeostasis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Castillo Bautista</LastName><ForeName>Cristina Marisol</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Center for Regenerative Therapies TU Dresden (CRTD), Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eismann</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Core Facility Mass Spectrometry &amp; Proteomics, Center for Molecular and Cellular Bioengineering, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentzel</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4482-6010</Identifier><AffiliationInfo><Affiliation>Core Facility Mass Spectrometry &amp; Proteomics, Center for Molecular and Cellular Bioengineering, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelucchi</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, La Jolla, CA 92161, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, Universit&#xe0; degli Studi di Milano, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mertens</LastName><ForeName>Jerome</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4291-4121</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, La Jolla, CA 92161, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Molecular Biology, University of Innsbruck, A-6020 Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walters</LastName><ForeName>Hannah E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Center for Regenerative Therapies TU Dresden (CRTD), Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yun</LastName><ForeName>Maximina H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0001-9019-2453</Identifier><AffiliationInfo><Affiliation>Center for Regenerative Therapies TU Dresden (CRTD), Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max Planck Institute for Molecular Cell Biology and Genetics, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cluster of Excellence Physics of Life, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterneckert</LastName><ForeName>Jared</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7688-3124</Identifier><AffiliationInfo><Affiliation>Center for Regenerative Therapies TU Dresden (CRTD), Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty Carl Gustav Carus of TU Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG056306</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG056306</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG056306</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ERC-STG-2019-852086</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>QN4128B52A</RegistryNumber><NameOfSubstance UI="C520962">obatoclax</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019253">Proto-Oncogene Proteins c-bcl-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019253" MajorTopicYN="N">Proto-Oncogene Proteins c-bcl-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">phenotypic screening</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37759469</ArticleId><ArticleId IdType="pmc">PMC10527391</ArticleId><ArticleId IdType="doi">10.3390/cells12182247</ArticleId><ArticleId IdType="pii">cells12182247</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Traxinger K., Kelly C., Johnson B.A., Lyles R.H., Glass J.D. Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997&#x2013;2011. Neurol. Clin. Pract. 2013;3:313&#x2013;320. doi: 10.1212/CPJ.0b013e3182a1b8ab.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0b013e3182a1b8ab</ArticleId><ArticleId IdType="pmc">PMC3787117</ArticleId><ArticleId IdType="pubmed">24195020</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: What do we really know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010;19:R46&#x2013;R64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Van Damme P., Van Den Bosch L. Inside out: The role of nucleocytoplasmic transport in ALS and FTLD. Acta Neuropathol. 2016;132:159&#x2013;173. doi: 10.1007/s00401-016-1586-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1586-5</ArticleId><ArticleId IdType="pmc">PMC4947127</ArticleId><ArticleId IdType="pubmed">27271576</ArticleId></ArticleIdList></Reference><Reference><Citation>Japtok J., Lojewski X., Naumann M., Klingenstein M., Reinhardt P., Sterneckert J., Putz S., Demestre M., Boeckers T.M., Ludolph A.C., et al. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol. Dis. 2015;82:420&#x2013;429. doi: 10.1016/j.nbd.2015.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.07.017</ArticleId><ArticleId IdType="pubmed">26253605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Lemay N., Ko H.K., Zhou H., Burke C., Kwiatkowski T.J., Jr., Sapp P., McKenna-Yasek D., Brown R.H., Jr., Hayward L.J. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 2010;19:4160&#x2013;4175. doi: 10.1093/hmg/ddq335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq335</ArticleId><ArticleId IdType="pmc">PMC2981014</ArticleId><ArticleId IdType="pubmed">20699327</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L., Poser I., Casci I., Japtok J., Reinhardt P., Janosch A., Andree C., Lee H.O., Moebius C., Koerner E., et al. Isogenic FUS-eGFP iPSC Reporter Lines Enable Quantification of FUS Stress Granule Pathology that Is Rescued by Drugs Inducing Autophagy. Stem Cell Rep. 2018;10:375&#x2013;389. doi: 10.1016/j.stemcr.2017.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.12.018</ArticleId><ArticleId IdType="pmc">PMC5857889</ArticleId><ArticleId IdType="pubmed">29358088</ArticleId></ArticleIdList></Reference><Reference><Citation>King O.D., Gitler A.D., Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012;1462:61&#x2013;80. doi: 10.1016/j.brainres.2012.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.01.016</ArticleId><ArticleId IdType="pmc">PMC3372647</ArticleId><ArticleId IdType="pubmed">22445064</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Choi J.M., Holehouse A.S., Lee H.O., Zhang X., Jahnel M., Maharana S., Lemaitre R., Pozniakovsky A., Drechsel D., et al. A Molecular Grammar Governing the Driving Forces for Phase Separation of Prion-like RNA Binding Proteins. Cell. 2018;174:688&#x2013;699.e16. doi: 10.1016/j.cell.2018.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.06.006</ArticleId><ArticleId IdType="pmc">PMC6063760</ArticleId><ArticleId IdType="pubmed">29961577</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., Stoynov S., Mahamid J., Saha S., Franzmann T.M., et al. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya V.A., Patani R. Decoding the relationship between ageing and amyotrophic lateral sclerosis: A cellular perspective. Brain. 2020;143:1057&#x2013;1072. doi: 10.1093/brain/awz360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz360</ArticleId><ArticleId IdType="pmc">PMC7174045</ArticleId><ArticleId IdType="pubmed">31851317</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky D.J., Petroni G., Amaravadi R.K., Baehrecke E.H., Ballabio A., Boya P., Bravo-San Pedro J.M., Cadwell K., Cecconi F., Choi A.M.K., et al. Autophagy in major human diseases. EMBO J. 2021;40:e108863. doi: 10.15252/embj.2021108863.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021108863</ArticleId><ArticleId IdType="pmc">PMC8488577</ArticleId><ArticleId IdType="pubmed">34459017</ArticleId></ArticleIdList></Reference><Reference><Citation>Boya P., Kroemer G. Beclin 1: A BH3-only protein that fails to induce apoptosis. Oncogene. 2009;28:2125&#x2013;2127. doi: 10.1038/onc.2009.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2009.83</ArticleId><ArticleId IdType="pubmed">19398951</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez A.F., Sebti S., Wei Y., Zou Z., Shi M., McMillan K.L., He C., Ting T., Liu Y., Chiang W.C., et al. Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice. Nature. 2018;558:136&#x2013;140. doi: 10.1038/s41586-018-0162-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0162-7</ArticleId><ArticleId IdType="pmc">PMC5992097</ArticleId><ArticleId IdType="pubmed">29849149</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino D., Kelly G.L., Lessene G., Wei A.H., Roberts A.W., Strasser A. BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines. Cancer Cell. 2018;34:879&#x2013;891. doi: 10.1016/j.ccell.2018.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2018.11.004</ArticleId><ArticleId IdType="pubmed">30537511</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L., Drexler H.C.A., Wang J., Tripathi P., Distler T., Heisterkamp P., Anderson E.N., Kour S., Moraiti A., Maharana S., et al. FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy. Acta Neuropathol. 2019;138:67&#x2013;84. doi: 10.1007/s00401-019-01998-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01998-x</ArticleId><ArticleId IdType="pmc">PMC6570784</ArticleId><ArticleId IdType="pubmed">30937520</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann J., Goswami R.Y., Girardo S., Rein N., Hosseinzadeh Z., Hicks M.R., Busskamp V., Pyle A.D., Werner C., Sterneckert J. A customizable microfluidic platform for medium-throughput modeling of neuromuscular circuits. Biomaterials. 2019;225:119537. doi: 10.1016/j.biomaterials.2019.119537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2019.119537</ArticleId><ArticleId IdType="pmc">PMC7294901</ArticleId><ArticleId IdType="pubmed">31614290</ArticleId></ArticleIdList></Reference><Reference><Citation>Shevchenko A., Wilm M., Vorm O., Mann M. Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels. Anal. Chem. 1996;68:850&#x2013;858. doi: 10.1021/ac950914h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac950914h</ArticleId><ArticleId IdType="pubmed">8779443</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasilj A., Gentzel M., Ueberham E., Gebhardt R., Shevchenko A. Tissue Proteomics by One-Dimensional Gel Electrophoresis Combined with Label-Free Protein Quantification. J. Proteome Res. 2012;11:3680&#x2013;3689. doi: 10.1021/pr300147z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr300147z</ArticleId><ArticleId IdType="pubmed">22671763</ArticleId></ArticleIdList></Reference><Reference><Citation>Demichev V., Messner C.B., Vernardis S.I., Lilley K.S., Ralser M. DIA-NN: Neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods. 2020;17:41&#x2013;44. doi: 10.1038/s41592-019-0638-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0638-x</ArticleId><ArticleId IdType="pmc">PMC6949130</ArticleId><ArticleId IdType="pubmed">31768060</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y., Csordas A., Bai J., Bernal-Llinares M., Hewapathirana S., Kundu D.J., Inuganti A., Griss J., Mayer G., Eisenacher M., et al. The PRIDE database and related tools and resources in 2019: Improving support for quantification data. Nucleic Acids Res. 2019;47:D442&#x2013;D450. doi: 10.1093/nar/gky1106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1106</ArticleId><ArticleId IdType="pmc">PMC6323896</ArticleId><ArticleId IdType="pubmed">30395289</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsch E.W., Bandeira N., Sharma V., Perez-Riverol Y., Carver J.J., Kundu D.J., Garc&#xed;a-Seisdedos D., Jarnuczak A.F., Hewapathirana S., Pullman B.S., et al. The ProteomeXchange consortium in 2020: Enabling &#x2018;big data&#x2019; approaches in proteomics. Nucleic Acids Res. 2020;48:D1145&#x2013;D1152. doi: 10.1093/nar/gkz984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz984</ArticleId><ArticleId IdType="pmc">PMC7145525</ArticleId><ArticleId IdType="pubmed">31686107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Smits A.H., van Tilburg G.B.A., Ovaa H., Huber W., Vermeulen M. Proteome-wide identification of ubiquitin interactions using UbIA-MS. Nat. Protoc. 2018;13:530&#x2013;550. doi: 10.1038/nprot.2017.147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2017.147</ArticleId><ArticleId IdType="pubmed">29446774</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen E.Y., Tan C.M., Kou Y., Duan Q., Wang Z., Meirelles G.V., Clark N.R., Ma&#x2019;ayan A. Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013;14:128. doi: 10.1186/1471-2105-14-128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov M.V., Jones M.R., Rouillard A.D., Fernandez N.F., Duan Q., Wang Z., Koplev S., Jenkins S.L., Jagodnik K.M., Lachmann A., et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90&#x2013;W97. doi: 10.1093/nar/gkw377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudman J., Qi X. Stress Granule Dysregulation in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci. 2020;14:598517. doi: 10.3389/fncel.2020.598517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.598517</ArticleId><ArticleId IdType="pmc">PMC7705167</ArticleId><ArticleId IdType="pubmed">33281563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J.J., Kuruvilla J., Mendelson D., Pishvaian M.J., Deeken J.F., Siu L.L., Berger M.S., Viallet J., Marshall J.L. Phase I dose finding studies of obatoclax (GX15-070), a small molecule pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma. Clin. Cancer Res. 2010;16:4038&#x2013;4045. doi: 10.1158/1078-0432.CCR-10-0822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-10-0822</ArticleId><ArticleId IdType="pmc">PMC3703245</ArticleId><ArticleId IdType="pubmed">20538761</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy F., Hurwitz J., McTavish N., Paul I., Barnes C., O&#x2019;Hagan B., Odrzywol K., Murray J., Longley D., McKerr G., et al. Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK. Cell Death Dis. 2010;1:e108. doi: 10.1038/cddis.2010.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2010.86</ArticleId><ArticleId IdType="pmc">PMC3032298</ArticleId><ArticleId IdType="pubmed">21368880</ArticleId></ArticleIdList></Reference><Reference><Citation>Basit F., Cristofanon S., Fulda S. Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ. 2013;20:1161&#x2013;1173. doi: 10.1038/cdd.2013.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2013.45</ArticleId><ArticleId IdType="pmc">PMC3741498</ArticleId><ArticleId IdType="pubmed">23744296</ArticleId></ArticleIdList></Reference><Reference><Citation>Koehler B.C., Jassowicz A., Scherr A.L., Lorenz S., Radhakrishnan P., Kautz N., Elssner C., Weiss J., Jaeger D., Schneider M., et al. Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling. BMC Cancer. 2015;15:919. doi: 10.1186/s12885-015-1929-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-015-1929-y</ArticleId><ArticleId IdType="pmc">PMC4653869</ArticleId><ArticleId IdType="pubmed">26585594</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle J.G., Lanson N.A., Jr., Smith R.B., Casci I., Maltare A., Monaghan J., Nichols C.D., Kryndushkin D., Shewmaker F., Pandey U.B. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum. Mol. Genet. 2013;22:1193&#x2013;1205. doi: 10.1093/hmg/dds526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds526</ArticleId><ArticleId IdType="pmc">PMC3578413</ArticleId><ArticleId IdType="pubmed">23257289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W.J., Sun Z.K., Shen C.T., Song H.J., Zhang X.Y., Qiu Z.L., Luo Q.Y. Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer. Theranostics. 2017;7:987&#x2013;1001. doi: 10.7150/thno.17322.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.17322</ArticleId><ArticleId IdType="pmc">PMC5381260</ArticleId><ArticleId IdType="pubmed">28382170</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo K.Y., Sultana J., King A.E., Atkinson R., Warraich S.T., Sundaramoorthy V., Blair I., Farg M.A., Atkin J.D. ALS-associated mutant FUS inhibits macroautophagy which is restored by overexpression of Rab1. Cell Death Discov. 2015;1:15030. doi: 10.1038/cddiscovery.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddiscovery.2015.30</ArticleId><ArticleId IdType="pmc">PMC4979432</ArticleId><ArticleId IdType="pubmed">27551461</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky D.J. The autophagosome is overrated! Autophagy. 2011;7:353&#x2013;354. doi: 10.4161/auto.7.4.14730.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.4.14730</ArticleId><ArticleId IdType="pmc">PMC3625117</ArticleId><ArticleId IdType="pubmed">21258205</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheroni C., Marino M., Tortarolo M., Veglianese P., De Biasi S., Fontana E., Zuccarello L.V., Maynard C.J., Dantuma N.P., Bendotti C. Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 2009;18:82&#x2013;96. doi: 10.1093/hmg/ddn319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn319</ArticleId><ArticleId IdType="pmc">PMC3298865</ArticleId><ArticleId IdType="pubmed">18826962</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., McAlary L., Lum J.S., Chisholm C.G., Warraich S.T., Blair I.P., Vine K.L., Saunders D.N., Yerbury J.J. Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS. iScience. 2020;23:101700. doi: 10.1016/j.isci.2020.101700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101700</ArticleId><ArticleId IdType="pmc">PMC7644588</ArticleId><ArticleId IdType="pubmed">33196025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Agar J.N., Taylor D.M., Minotti S., Durham H.D. Focal dysfunction of the proteasome: A pathogenic factor in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2004;89:1325&#x2013;1335. doi: 10.1111/j.1471-4159.2004.02453.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02453.x</ArticleId><ArticleId IdType="pubmed">15189335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Agar J.N., Strong M.J., Durham H.D. Impaired proteasome function in sporadic amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13:367&#x2013;371. doi: 10.3109/17482968.2012.686511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.686511</ArticleId><ArticleId IdType="pubmed">22632443</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashiro Y., Urushitani M., Inoue H., Koike M., Uchiyama Y., Komatsu M., Tanaka K., Yamazaki M., Abe M., Misawa H., et al. Motor Neuron-specific Disruption of Proteasomes, but Not Autophagy, Replicates Amyotrophic Lateral Sclerosis. J. Biol. Chem. 2012;287:42984&#x2013;42994. doi: 10.1074/jbc.M112.417600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.417600</ArticleId><ArticleId IdType="pmc">PMC3522293</ArticleId><ArticleId IdType="pubmed">23095749</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshihara T., Satake H., Nishie T., Okino N., Hatta T., Otani H., Naruse C., Suzuki H., Sugihara K., Kamimura E., et al. Lactosylceramide synthases encoded by B4galt5 and 6 genes are pivotal for neuronal generation and myelin formation in mice. PLoS Genet. 2018;14:e1007545. doi: 10.1371/journal.pgen.1007545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007545</ArticleId><ArticleId IdType="pmc">PMC6095488</ArticleId><ArticleId IdType="pubmed">30114188</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishie T., Hikimochi Y., Zama K., Fukusumi Y., Ito M., Yokoyama H., Naruse C., Ito M., Asano M. Beta4-galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development. Glycobiology. 2010;20:1311&#x2013;1322. doi: 10.1093/glycob/cwq098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwq098</ArticleId><ArticleId IdType="pubmed">20574042</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiricozzi E., Lunghi G., Di Biase E., Fazzari M., Sonnino S., Mauri L. GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration. Int. J. Mol. Sci. 2020;21:868. doi: 10.3390/ijms21030868.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21030868</ArticleId><ArticleId IdType="pmc">PMC7037093</ArticleId><ArticleId IdType="pubmed">32013258</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazzari M., Lunghi G., Henriques A., Callizot N., Ciampa M.G., Mauri L., Prioni S., Carsana E.V., Loberto N., Aureli M., et al. GM1 Oligosaccharide Efficacy in Parkinson&#x2019;s Disease: Protection against MPTP. Biomedicines. 2023;11:1305. doi: 10.3390/biomedicines11051305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11051305</ArticleId><ArticleId IdType="pmc">PMC10216367</ArticleId><ArticleId IdType="pubmed">37238977</ArticleId></ArticleIdList></Reference><Reference><Citation>Pestronk A., Adams R.N., Clawson L., Cornblath D., Kuncl R.W., Griffin D., Drachman D.B. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology. 1988;38:1457&#x2013;1461. doi: 10.1212/WNL.38.9.1457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.38.9.1457</ArticleId><ArticleId IdType="pubmed">3412595</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong T.G., Neff N.H., Hadjiconstantinou M. GM1 ganglioside improves spatial learning and memory of aged rats. Behav. Brain Res. 1997;85:203&#x2013;211. doi: 10.1016/S0166-4328(97)87584-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-4328(97)87584-5</ArticleId><ArticleId IdType="pubmed">9105576</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma M., Naslavsky N., Caplan S. A role for EHD4 in the regulation of early endosomal transport. Traffic. 2008;9:995&#x2013;1018. doi: 10.1111/j.1600-0854.2008.00732.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2008.00732.x</ArticleId><ArticleId IdType="pmc">PMC2795359</ArticleId><ArticleId IdType="pubmed">18331452</ArticleId></ArticleIdList></Reference><Reference><Citation>Canagarajah B.J., Ren X., Bonifacino J.S., Hurley J.H. The clathrin adaptor complexes as a paradigm for membrane-associated allostery. Protein Sci. 2013;22:517&#x2013;529. doi: 10.1002/pro.2235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.2235</ArticleId><ArticleId IdType="pmc">PMC3649254</ArticleId><ArticleId IdType="pubmed">23424177</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivero S., Rodr&#xed;guez-Real G., Mar&#xed;n I., Huertas P. MRGBP, a member of the NuA4 complex, inhibits DNA double-strand break repair. FEBS Open Bio. 2021;11:622&#x2013;632. doi: 10.1002/2211-5463.13071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.13071</ArticleId><ArticleId IdType="pmc">PMC7931222</ArticleId><ArticleId IdType="pubmed">33354938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond C.M., Bao H., Hendriks I.A., Carraro M., Garc&#xed;a-Nieto A., Liu Y., Rever&#xf3;n-G&#xf3;mez N., Spanos C., Chen L., Rappsilber J., et al. DNAJC9 integrates heat shock molecular chaperones into the histone chaperone network. Mol. Cell. 2021;81:2533&#x2013;2548.e9. doi: 10.1016/j.molcel.2021.03.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.03.041</ArticleId><ArticleId IdType="pmc">PMC8221569</ArticleId><ArticleId IdType="pubmed">33857403</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki Y., Manzano R., Lee Y., Dafinca R., Aoki M., Douglas A.G.L., Varela M.A., Sathyaprakash C., Scaber J., Barbagallo P., et al. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain. 2017;140:887&#x2013;897. doi: 10.1093/brain/awx024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx024</ArticleId><ArticleId IdType="pubmed">28334866</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.J., Mitchell J.C., Novoselov S., Miller J., Nishimura A.L., Scotter E.L., Vance C.A., Cheetham M.E., Shaw C.E. The heat shock response plays an important role in TDP-43 clearance: Evidence for dysfunction in amyotrophic lateral sclerosis. Brain. 2016;139:1417&#x2013;1432. doi: 10.1093/brain/aww028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww028</ArticleId><ArticleId IdType="pmc">PMC4845254</ArticleId><ArticleId IdType="pubmed">26936937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourelatos Z., Adler H., Hirano A., Donnenfeld H., Gonatas J.O., Gonatas N.K. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis revealed by organelle-specific antibodies. Proc. Natl. Acad. Sci. USA. 1990;87:4393&#x2013;4395. doi: 10.1073/pnas.87.11.4393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.11.4393</ArticleId><ArticleId IdType="pmc">PMC54116</ArticleId><ArticleId IdType="pubmed">2349244</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., Gunther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwenk B.M., Hartmann H., Serdaroglu A., Schludi M.H., Hornburg D., Meissner F., Orozco D., Colombo A., Tahirovic S., Michaelsen M., et al. TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons. EMBO J. 2016;35:2350&#x2013;2370. doi: 10.15252/embj.201694221.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694221</ArticleId><ArticleId IdType="pmc">PMC5090220</ArticleId><ArticleId IdType="pubmed">27621269</ArticleId></ArticleIdList></Reference><Reference><Citation>Seminary E.R., Sison S.L., Ebert A.D. Modeling Protein Aggregation and the Heat Shock Response in ALS iPSC-Derived Motor Neurons. Front. Neurosci. 2018;12:86. doi: 10.3389/fnins.2018.00086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00086</ArticleId><ArticleId IdType="pmc">PMC5826239</ArticleId><ArticleId IdType="pubmed">29515358</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dis V., Kuijpers M., Haasdijk E.D., Teuling E., Oakes S.A., Hoogenraad C.C., Jaarsma D. Golgi fragmentation precedes neuromuscular denervation and is associated with endosome abnormalities in SOD1-ALS mouse motor neurons. Acta Neuropathol. Commun. 2014;2:38. doi: 10.1186/2051-5960-2-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-38</ArticleId><ArticleId IdType="pmc">PMC4023628</ArticleId><ArticleId IdType="pubmed">24708899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Guo W., Mitra J., Hegde P.M., Vandoorne T., Eckelmann B.J., Mitra S., Tomkinson A.E., Van Den Bosch L., Hegde M.L. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. Nat. Commun. 2018;9:3683. doi: 10.1038/s41467-018-06111-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06111-6</ArticleId><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelino S., Chang J.T., Kumsta C., She X., Davis A., Nguyen C., Panowski S., Hansen M. Intestinal Autophagy Improves Healthspan and Longevity in C. elegans during Dietary Restriction. PLOS Genet. 2016;12:e1006135. doi: 10.1371/journal.pgen.1006135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006135</ArticleId><ArticleId IdType="pmc">PMC4945006</ArticleId><ArticleId IdType="pubmed">27414651</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.A., Harrison D.E., Astle C.M., Fernandez E., Flurkey K., Han M., Javors M.A., Li X., Nadon N.L., Nelson J.F., et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell. 2014;13:468&#x2013;477. doi: 10.1111/acel.12194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12194</ArticleId><ArticleId IdType="pmc">PMC4032600</ArticleId><ArticleId IdType="pubmed">24341993</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen M., Marcellus R.C., Roulston A., Watson M., Serfass L., Murthy Madiraju S.R., Goulet D., Viallet J., Belec L., Billot X., et al. Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc. Natl. Acad. Sci. USA. 2007;104:19512&#x2013;19517. doi: 10.1073/pnas.0709443104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0709443104</ArticleId><ArticleId IdType="pmc">PMC2148320</ArticleId><ArticleId IdType="pubmed">18040043</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahheydari H., Ragagnin A., Walker A.K., Toth R.P., Vidal M., Jagaraj C.J., Perri E.R., Konopka A., Sultana J.M., Atkin J.D. Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum. Front. Mol. Neurosci. 2017;10:119. doi: 10.3389/fnmol.2017.00119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00119</ArticleId><ArticleId IdType="pmc">PMC5423993</ArticleId><ArticleId IdType="pubmed">28539871</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y.-L., Duan W.-J., Lu D.-H., Ma X.-H., Li X.-X., Li Z., Bi W., Kurihara H., Liu H.-Z., Li Y.-F., et al. Autophagy-dependent removal of &#x3b1;-synuclein: A novel mechanism of GM1 ganglioside neuroprotection against Parkinson&#x2019;s disease. Acta Pharmacol. Sin. 2021;42:518&#x2013;528. doi: 10.1038/s41401-020-0454-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-0454-y</ArticleId><ArticleId IdType="pmc">PMC8115090</ArticleId><ArticleId IdType="pubmed">32724177</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai R., Zhang S., Duan W., Wei R., Chen H., Cai W., Yang L., Wang Q. Enhanced Autophagy Contributes to Protective Effects of GM1 Ganglioside Against A&#x3b2;1-42-Induced Neurotoxicity and Cognitive Deficits. Neurochem. Res. 2017;42:2417&#x2013;2426. doi: 10.1007/s11064-017-2266-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2266-0</ArticleId><ArticleId IdType="pubmed">28497346</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C., Xie C., Shim H., Chandran J., Howell B.W., Cai H. Regulation of endosomal motility and degradation by amyotrophic lateral sclerosis 2/alsin. Mol. Brain. 2009;2:23. doi: 10.1186/1756-6606-2-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-2-23</ArticleId><ArticleId IdType="pmc">PMC2724476</ArticleId><ArticleId IdType="pubmed">19630956</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K.F., Su J.C., Liu C.Y., Huang J.W., Chen K.C., Chen W.L., Tai W.T., Shiau C.W. A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation. Cancer Lett. 2012;321:27&#x2013;35. doi: 10.1016/j.canlet.2012.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2012.03.023</ArticleId><ArticleId IdType="pubmed">22465052</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani M., Aust M.M., Attkisson E., Williams D.C., Jr., Ferreira-Gonzalez A., Grant S. Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process. Blood. 2012;119:6089&#x2013;6098. doi: 10.1182/blood-2011-09-378141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-09-378141</ArticleId><ArticleId IdType="pmc">PMC3383017</ArticleId><ArticleId IdType="pubmed">22446485</ArticleId></ArticleIdList></Reference><Reference><Citation>Trudel S., Li Z.H., Rauw J., Tiedemann R.E., Wen X.Y., Stewart A.K. Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma. Blood. 2007;109:5430&#x2013;5438. doi: 10.1182/blood-2006-10-047951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2006-10-047951</ArticleId><ArticleId IdType="pubmed">17332241</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien S.M., Claxton D.F., Crump M., Faderl S., Kipps T., Keating M.J., Viallet J., Cheson B.D. Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia. Blood. 2009;113:299&#x2013;305. doi: 10.1182/blood-2008-02-137943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-02-137943</ArticleId><ArticleId IdType="pmc">PMC4968372</ArticleId><ArticleId IdType="pubmed">18931344</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimmer A.D., O&#x2019;Brien S., Kantarjian H., Brandwein J., Cheson B.D., Minden M.D., Yee K., Ravandi F., Giles F., Schuh A., et al. A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies. Clin. Cancer Res. 2008;14:8295&#x2013;8301. doi: 10.1158/1078-0432.CCR-08-0999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-08-0999</ArticleId><ArticleId IdType="pubmed">19088047</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlosser A., Volkmer-Engert R. Volatile polydimethylcyclosiloxanes in the ambient laboratory air identified as source of extreme background signals in nanoelectrospray mass spectrometry. J. Mass. Spectrom. 2003;38:523&#x2013;525. doi: 10.1002/jms.465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jms.465</ArticleId><ArticleId IdType="pubmed">12794873</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters H.E., Troyanovskiy K.E., Graf A.M., Yun M.H. Senescent cells enhance newt limb regeneration by promoting muscle dedifferentiation. Aging Cell. 2023;22:e13826. doi: 10.1111/acel.13826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13826</ArticleId><ArticleId IdType="pmc">PMC10265169</ArticleId><ArticleId IdType="pubmed">37025070</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>